Literature DB >> 31254973

Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency.

Laura Martos1, Álvaro Fernández-Pardo1, María F López-Fernández2, Francisco Ibáñez3, Sonia Herrero4, Dolors Tàssies5, José R González-Porras6, María J Solmoirago1, María J Costa2, Juan C Reverter5, Pascual Marco7, Vanessa Roldán8, Ramón Lecumberri9, Francisco Velasco10, Julia Oto1, Gemma Iruin11, María N Alonso12, Amparo Vayá1, Santiago Bonanad1,13, Fernando Ferrando1,13, Edelmira Martí14, Ana R Cid1,13, Emma Plana1, Francisca Oña15, Isabel Cuesta16, Tomás J González-López17, Francisco España1, Pilar Medina1, Silvia Navarro1.   

Abstract

Presently, no data on the molecular basis of hereditary protein C (PC) deficiency in Spain is available. We analyzed the PC gene (PROC) in 109 patients with symptomatic PC deficiency and in 342 relatives by sequencing the 9 PROC exons and their flanking intron regions. In 93 probands, we found 58 different mutations (26 novel). Thirty-seven consisted of a nucleotide change, mainly missense mutations, 1 was a 6-nucleotide insertion causing the duplication of 2 amino acids, and 4 were deletions of 1, 3, 4, and 16 nucleotides. Nine mutations caused type II deficiencies, with the presence of normal antigen levels but reduced anticoagulant activity. Using a PC level of 70% as lowest normal limit, we found no mutations in 16 probands and 25 relatives with PC levels ≤ 70%. On the contrary, 4 probands and 12 relatives with PC levels > 70% carried the mutation identified in the proband. The spectrum of recurrent mutations in Spain is different from that found in the Netherlands, where the most frequent mutations were p.Gln174* and p.Arg272Cys, and is more similar to that found in France, where the most frequent were p.Arg220Gln and p.Pro210Leu. In our study, p.Val339Met (9 families), p.Tyr166Cys (7), p.Arg220Gln (6), and p.Glu58Lys (5) were the most prevalent. This study confirms the considerable heterogeneity of the genetic abnormality in PC deficiencies, and allowed genetic counseling to those individuals whose PC levels were close to the lower limit of the normal reference range. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31254973     DOI: 10.1055/s-0039-1692440

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  2 in total

1.  A Series of 14 Polish Patients with Thrombotic Events and PC Deficiency-Novel c.401-1G>A PROC Gene Splice Site Mutation in a Patient with Aneurysms.

Authors:  Anna Weronska; Daniel P Potaczek; Julia Oto; Pilar Medina; Anetta Undas; Ewa Wypasek
Journal:  Genes (Basel)       Date:  2022-04-22       Impact factor: 4.141

2.  Laboratory Limitations of Excluding Hereditary Protein C Deficiency by Chromogenic Assay: Discrepancies of Phenotype and Genotype.

Authors:  Holger Seidel; Bianca Haracska; Jennifer Naumann; Philipp Westhofen; Moritz Sebastian Hass; Johannes Philipp Kruppenbacher
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.